Selective histone deacetylase inhibitors for the treatment of human disease
US11034667B2 · kind B2 · utility
0Cited by
78References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2018 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Jan 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Selective HDAC inhibitors, and pharmaceutical compositions that include the same, are described herein for the treatment of cancer, immunological diseases, inflammatory diseases, and neurological diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.